COVID-19, like other infectious diseases, may be a risk factor for a rst episode of psychosis or psychotic relapse. We aimed to compare the proportions of hospitalizations for psychotic disorders in the 12 months following discharge from hospital for either COVID-19 or for another reason in the adult general population in France during the rst wave of the pandemic.We conducted a retrospective longitudinal nationwide study using the national French administrative healthcare database. Psychotic disorders were rst studied as a whole, and then chronic and acute disorders separately. The role of several adjustment factors, including sociodemographics, a history of psychotic disorder, the duration of the initial hospitalization, and the level of care received during that hospitalization, were also analyzed.Between 1 January 2020 and 30 June 2020, a total of 14,622 patients were hospitalized for psychotic disorders in the 12 months following discharge from hospital for either COVID-19 or another reason. Initial hospitalization for COVID-19 (vs. another reason) was associated with a lower rate of subsequent hospitalization for psychotic disorders (0.31 % vs. 0.51 %, OR = 0.60, 95% CI [0.53-0.67]). This was true for both chronic and acute disorders, even after adjusting for the various study variables. Importantly, a history of psychotic disorder was a major determinant of hospitalization for psychotic disorders (aOR = 126.56,).Our results suggest that individuals initially hospitalized for COVID-19 (vs. another reason) present a lower risk of hospitalization for rst episodes of psychotic symptoms/disorders or for psychotic relapse in the 12 months following discharge. This nding contradicts invalidates the hypothesis that there is a higher risk of psychotic disorders after a severe COVID-19. adjustment factors. In the fully adjusted model, (i.e., taking into account socio-demographic characteristics, history of psychiatric disorders and the levels of care intensity), the association was not signi cant.In the present study, we focused on psychotic disorders. More speci cally, we described the different kinds of psychotic disorders, and separately analyzed acute vs. chronic psychotic disorders. Indeed, showing different patterns of association for different psychotic disorders -especially acute psychotic disorders which may re ect FEP -could add signi cant knowledge about the relationships between COVID-19 and psychotic disorders. Moreover, we could analyze if the psychotic disorder was the main reason of the hospitalization ("main" diagnosis) or if it was considered a comorbid condition of the main reason of the hospitalization ("associated" diagnosis). In this last case, we could investigate how COVID-19 could increase global health vulnerability among subjects with psychotic disorders (by analyzing different types of hospitalization, in psychiatric and non-psychiatric wards).To act on these research possibilities, using the same dataset employed for our study on psychiatric disorders in the whole French Metropolitan gen...